Enanta Pharmaceuticals
ENTA
ENTA
172 hedge funds and large institutions have $857M invested in Enanta Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 76 increasing their positions, 55 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
7% less capital invested
Capital invested by funds: $917M → $857M (-$60.3M)
33% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 24
100% less call options, than puts
Call options by funds: $4K | Put options by funds: $2.15M
Holders
172
Holding in Top 10
1
Calls
$4K
Puts
$2.15M
Top Buyers
| 1 | +$19.2M | |
| 2 | +$9.16M | |
| 3 | +$8.48M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$4M |
| 5 |
Renaissance Technologies
New York
|
+$3.94M |
Top Sellers
| 1 | -$14.1M | |
| 2 | -$5.97M | |
| 3 | -$4.43M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$4.38M |
| 5 |
WG
Winton Group
London,
United Kingdom
|
-$3.11M |